Vimkunya is now available in the US for the prevention of disease caused by chikungunya virus in individuals 12 years of age ...

The Uttarakhand Health Department has issued updated guidelines and Standard Operating Procedures (SoPs) for the management ...

Discover how a structural breakthrough in the chikungunya virus is opening new avenues for antiviral drug development and ...

Valneva receives Brazilian marketing authorization for single-dose vaccine Ixchiq for prevention of disease caused by chikungunya virus: Saint Herblain, France Wednesday, April 16 ...

Valneva's chikungunya vaccine Ixchiq receives Brazil approval, enabling expanded trials and access across Latin America and ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company today announced that the Brazilian Health Regulatory Agency (ANVISA) has granted marketing authorization to its single-dose ...

The study conducted by IIT Roorkee is supported by the Indian Council of Medical Research (ICMR). It has been published in a ...

Valneva (VALN) announced that the Brazilian Health Regulatory Agency has granted marketing authorization to its single-dose vaccine Ixchiq for ...

Dengue and chikungunya are spread by the Aedes aegypti mosquito. Symptoms appear within 7 days of being bitten by a mosquito.

Vimkunya is supplied as an injectable suspension; the vaccine is administered intramuscular as a single 0.8mL dose. Vimkunya ™ (chikungunya vaccine, recombinant) is now available in the US for ...